Cepheid
Sunnyvale, United States · Biotechnology, Genetics, Health Care
Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility. The company's GeneXpert® systems and Xpert® tests automate highly complex and time-consuming manual procedures, providing A Better Way for institutions of any size to perform world-class PCR testing. Cepheid’s broad test portfolio spans respiratory infections, blood virol
Key facts
- Headquarters
- Sunnyvale, United States
- Employees
- 4,800
- Industries
- Biotechnology, Genetics, Health Care
- Status
- Private
- Website
- www.cepheid.com
- Company page
Recent activity at Cepheid
Leadership
- Piotr Zima, Chief Information Officer
- Simon Peneau, Labor and Employee Relations (LER) Liaison - Cepheid Europe
- Carlos Castillo, Principal Program Manager, Molecular Diagnostics Systems
- Vitor Rocha, Vice President of Product
Verified email and direct lines for Cepheid’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Cepheid files 2 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Cepheid in the news
- Cepheid Receives CE Marking Under IVDR for Xpert® GI Panel - PR Newswire (May 13, 2026)
- Cepheid and Oxford Nanopore Expand Partnership Following Successful Phase One Collaboration - BioSpace (Apr 15, 2026)
- Cepheid Receives FDA Clearance for Xpert® GI Panel to Support Broad Detection of Gastrointestinal Pathogens - PR Newswire (Jan 20, 2026)
- Cepheid Receives FDA Clearance for Xpert® Respiratory Panel to Aid in the Diagnosis of Respiratory Tract Infection - PR Newswire (Sep 29, 2026)
- Cepheid Receives FDA Clearance for Xpert® Hemorrhagic Fever Panel Test - PR Newswire (Nov 03, 2026)
- Cepheid Selected by CDC as National Collaborator, Advancing Rapid Diagnostic Innovation to Strengthen U.S. Pandemic Preparedness - PR Newswire (Feb 18, 2026)
- Cepheid Announces World Health Organization Prequalification of the Xpert® MTB/XDR test - PR Newswire (Oct 28, 2025)
- Cepheid Receives FDA Clearance for Xpert® Xpress GBS - PR Newswire (Mar 11, 2024)
Companies similar to Cepheid
- Grail · Biotechnology, Genetics, Health Care, Health Diagnostics, Medical
- Natera · Biotechnology, Genetics, Health Care, Health Diagnostics
- BioMarin Pharmaceutical · Biotechnology, Genetics, Health Care, Medical
- Avanos Medical · Biotechnology, Health Care, Health Diagnostics, Medical
- NeoGenomics · Biotechnology, Health Care, Health Diagnostics, Medical
About Cepheid: questions and answers
What does Cepheid do?
Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility. The company's GeneXpert® systems and Xpert® tests automate highly complex and time-consuming manual procedures, providing A Better Way for institutions of any size to perform world-class PCR testing. Cepheid’s broad test portfolio spans respiratory infections, blood virol
Where is Cepheid headquartered?
Cepheid is headquartered in Sunnyvale, United States.
How many employees does Cepheid have?
Cepheid has about 4,800 employees.
Who leads Cepheid?
Vitor Rocha is a Vice President of Product at Cepheid.
What is the latest news on Cepheid?
On Jul 24, 2026, Cepheid Appoints Piotr Zima as Chief Information Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy